Antigua and Barbuda

Show data as of
'Most recent data' shows most recent policy adoption levels and other data. Choosing a year shows data available for that year only.
Antigua and Barbuda
Show data as of
'Most recent data' shows most recent policy adoption levels and other data. Choosing a year shows data available for that year only.
scroll to top
HIV Policy Lab

Overall country policy adoption
Overall policy adoption scale
Calculated for each country based on the percent of policies for which data are available that have have a score of “adopted”
VERY FEW
0-19% of policies have been adopted
FEW
20-39% of policies
SOME
40-59%
MANY
60-79%
MOST
80%+

VERY FEW
FEW
SOME
MANY
MOST
policies adopted

Policy adoption

(out of 33)

12
Adopted
9
Partial
9
Not adopted
3
Data not available

HIV incidence

No data

ART treatment

No data

Policy adoption by category

VERY FEW
MOST

Overall

VERY FEW
MOST
global average
regional average

Clinical and treatment

VERY FEW
MOST

Testing and prevention

VERY FEW
MOST

Structural

VERY FEW
MOST

Health systems

VERY FEW
MOST

Policy adoption by question

Clinical and treatment
Contact Us
CT
MOST
Category / topic
Question
Adoption level
Not
adopted
Partially
adopted
Adopted
CT1
Treatment initiation
CT1
Treatment initiation
Clinical and treatment
Policy 1
Are all people living with HIV, regardless of CD4 count, eligible to start HIV treatment in national policy?
Data available for
2017
2018
2019
2020
2021
2022
2023
2024
Source data not currently available
Are all people living with HIV, regardless of CD4 count, eligible to start HIV treatment in national policy?
CT2
Same-day treatment start
CT2
Same-day treatment start
Clinical and treatment
Policy 2
Is the option to start treatment the same day as HIV diagnosis included in national policy?
Data available for
2017
2018
2019
2020
2021
2022
2023
2024
Source: NCPI (2020)
Is the option to start treatment the same day as HIV diagnosis included in national policy?
CT3
Treatment regimen
CT3
Treatment regimen
Clinical and treatment
Policy 3
Are up-to-date first-line ARV regimens aligned with international recommendations included in national HIV policy?
Data available for
2017
2018
2019
2020
2021
2022
2023
2024
Source: NCPI (2020)
Are up-to-date first-line ARV regimens aligned with international recommendations included in national HIV policy?
CT4
Differentiated service delivery (3‑part)
CT4
Differentiated service delivery
Clinical and treatment
Policy 4
Do national HIV treatment policies include multiple options for differentiated HIV treatment services?
Data available for
i
2017
2018
2019
2020
2021
2022
2023
2024
Source: NCPI (2020)
ii
2017
2018
2019
2020
2021
2022
2023
2024
Source: NCPI (2020)
iii
2017
2018
2019
2020
2021
2022
2023
2024
Source: NCPI (2020)
Do national HIV treatment policies include multiple options for differentiated HIV treatment services?
i
Does national policy allow for community ART distribution?
ii
Does national policy allow for reduced frequency of clinical visits?
iii
Does national policy allow for multi-month dispensing?
CT5
Viral load testing
CT5
Viral load testing
Clinical and treatment
Policy 5
Is viral load monitoring at least once per year provided for in national policy?
Data available for
2017
2018
2019
2020
2021
2022
2023
2024
Source: NCPI Part A (2019)
Is viral load monitoring at least once per year provided for in national policy?
CT6
Pediatric diagnosis & treatment (2‑part)
CT6
Pediatric diagnosis & treatment
Clinical and treatment
Policy 6
Are national pediatric testing and treatment policies aligned with international recommendations?
Data available for
i
2017
2018
2019
2020
2021
2022
2023
2024
Source: NCPI (2020)
ii
2017
2018
2019
2020
2021
2022
2023
2024
Source: NCPI (2020)
Are national pediatric testing and treatment policies aligned with international recommendations?
i
Does early infant diagnosis policy align with WHO recommendations on the use of point-of-care tests?
ii
Does the first-line ARV regimen for infants and children included in national guidelines align with WHO recommendations?
CT7
Migrants access to healthcare (2‑part)
CT7
Migrants access to healthcare
Clinical and treatment
Policy 7
Are HIV services and primary healthcare available to all migrants under the same conditions as citizens under national policy?
Data available for
i
2017
2018
2019
2020
2021
2022
2023
2024
Source data not currently available
ii
2017
2018
2019
2020
2021
2022
2023
2024
Source data not currently available
Are HIV services and primary healthcare available to all migrants under the same conditions as citizens under national policy?
data not available
i
Is primary healthcare available to all migrants under the same conditions as citizens under national policy?
data not available
ii
Are HIV services available to all migrants under the same conditions as citizens under national policy?
data not available
CT8
TB diagnostics
CT8
TB diagnostics
Clinical and treatment
Policy 8
Are rapid diagnostic tests (e.g. rapid molecular diagnostics, TB-LAM) aligned with WHO recommendations used as the initial diagnostic test for TB in PLHIV under national policy?
Data available for
2017
2018
2019
2020
2021
2022
2023
2024
Source: WHO Global TB Report (2020)
Are rapid diagnostic tests (e.g. rapid molecular diagnostics, TB-LAM) aligned with WHO recommendations used as the initial diagnostic test for TB in PLHIV under national policy?
Testing and prevention
Contact Us
TP
FEW
Category / topic
Question
Adoption level
Not
adopted
Partially
adopted
Adopted
TP1
Self-testing
TP1
Self-testing
Testing and prevention
Policy 1
Is self-testing approved in national policy?
Data available for
2017
2018
2019
2020
2021
2022
2023
2024
Source: NCPI (2021)
Is self-testing approved in national policy?
TP2
Partner notification/Index testing (2‑part)
TP2
Partner notification/Index testing
Testing and prevention
Policy 2
Is index testing/partner notification, with robust protections for patient confidentiality, provided for in national policy?
Data available for
i
2017
2018
2019
2020
2021
2022
2023
2024
Source: NCPI (2020)
ii
2017
2018
2019
2020
2021
2022
2023
2024
Source data not currently available
Is index testing/partner notification, with robust protections for patient confidentiality, provided for in national policy?
i
Is index testing/partner notification provided for in national guidelines?
ii
Do partner notification guidelines include confidentiality and robust protections against disclosure of HIV status without patients consent?
data not available
TP3
Compulsory testing
TP3
Compulsory testing
Testing and prevention
Policy 3
Is compulsory HIV testing prohibited under national law?
Data available for
2017
2018
2019
2020
2021
2022
2023
2024
Source: NCPI Part A (2019)
Is compulsory HIV testing prohibited under national law?
TP4
Age restrictions on testing & treatment
TP4
Age restrictions on testing & treatment
Testing and prevention
Policy 4
Can adolescents access HIV testing and treatment without parental consent under national policy?
Data available for
2017
2018
2019
2020
2021
2022
2023
2024
Source: NCPI Part A (2019)
Can adolescents access HIV testing and treatment without parental consent under national policy?
TP5
PrEP (2‑part)
TP5
PrEP
Testing and prevention
Policy 5
Are all people/populations at substantial risk of HIV infection eligible for PrEP under national policy and have technologies for pre-exposure prophylaxis (PrEP) received national regulatory approval?
Data available for
i
2017
2018
2019
2020
2021
2022
2023
2024
Source: ATG_2019_countryreport (2019)
ii
2017
2018
2019
2020
2021
2022
2023
2024
Source: 2022_Antigua_New HIV Prevention Drug Available in Antigua
Are all people/populations at substantial risk of HIV infection eligible for PrEP under national policy and have technologies for pre-exposure prophylaxis (PrEP) received national regulatory approval?
i
Are people/populations at substantial risk of HIV infection identified and eligible for PrEP under national policy?
ii
Has at least one form of PrEP received national regulatory approval?
TP6
Harm reduction (2‑part)
TP6
Harm reduction
Testing and prevention
Policy 6
Does national law and HIV policy incorporate key harm reduction strategies, including avoidance of criminalizing syringe possession?
Data available for
i
2017
2018
2019
2020
2021
2022
2023
2024
Source: (2022)_The_Global_State_of_Harm_Reduction
ii
2017
2018
2019
2020
2021
2022
2023
2024
Source: NCPI Part A (2019)
Does national law and HIV policy incorporate key harm reduction strategies, including avoidance of criminalizing syringe possession?
i
Is harm reduction included in national policy & service packages for people who inject drugs?
ii
Does national law avoid imposing criminal penalties for possession of syringes and associated paraphernalia?
TP7
Comprehensive sexuality education
TP7
Comprehensive sexuality education
Testing and prevention
Policy 7
Is comprehensive sexuality education required in primary and secondary schools under national policy?
Data available for
2017
2018
2019
2020
2021
2022
2023
2024
Source: NCPI Part A (2019)
Is comprehensive sexuality education required in primary and secondary schools under national policy?
TP8
Prisoners prevention (2‑part)
TP8
Prisoners prevention
Testing and prevention
Policy 8
Are both condoms/lubricants and syringe access/exchange programs available to prisoners as a matter of policy?
Data available for
i
2017
2018
2019
2020
2021
2022
2023
2024
Source: NCPI Part B (2022)
ii
2017
2018
2019
2020
2021
2022
2023
2024
Source: NCPI Part A (2019)
Are both condoms/lubricants and syringe access/exchange programs available to prisoners as a matter of policy?
i
Are condoms/lubricant available in prisons as a matter of national policy?
ii
Are syringe access/exchange programs available in prisons as a matter of national policy?
Structural
Contact Us
S
SOME
Category / topic
Question
Adoption level
Not
adopted
Partially
adopted
Adopted
S1
Same-sex sex non-criminalization (2‑part)
S1
Same-sex sex non-criminalization
Structural
Policy 1
Does national law/policy refrain from criminalizing and prosecuting people for consensual same-sex sexual acts?
Data available for
i
2017
2018
2019
2020
2021
2022
2023
2024
Sources: (2022)_Antigua And Barbuda_High Court RulingAntigua and Barbuda Sexual Offences Act (1995)(2022)_Antigua And Barbuda_High Court Ruling
ii
2017
2018
2019
2020
2021
2022
2023
2024
Source: NCPI Part B (2022)
Does national law/policy refrain from criminalizing and prosecuting people for consensual same-sex sexual acts?
i
Does national law refrain from criminalizing consensual same-sex sexual acts?
ii
Has law-enforcement policy avoided prosecution for consensual same-sex acts in recent years?
S2
Sex work non-criminalization
S2
Sex work non-criminalization
Structural
Policy 2
Does national law avoid criminalizing sex work (buying, selling, and organizing of sex work)?
Data available for
2017
2018
2019
2020
2021
2022
2023
2024
Sources: NSWP (2023)NCPI Part A (2022)
Does national law avoid criminalizing sex work (buying, selling, and organizing of sex work)?
S3
Drug use non-criminalization
S3
Drug use non-criminalization
Structural
Policy 3
Does national law refrain from criminalizing personal drug use/possession?
Data available for
2017
2018
2019
2020
2021
2022
2023
2024
Sources: IDPC (2021)NCPI Part A (2022)
Does national law refrain from criminalizing personal drug use/possession?
S4
HIV exposure non-criminalization (2‑part)
S4
HIV exposure non-criminalization
Structural
Policy 4
Does national law refrain from criminalizing and prosecuting people for HIV exposure/ transmission?
Data available for
i
2017
2018
2019
2020
2021
2022
2023
2024
Sources: HIV Justice Network (2020)NCPI Part A (2022)
ii
2017
2018
2019
2020
2021
2022
2023
2024
Source: HIV Justice Network (2020)
Does national law refrain from criminalizing and prosecuting people for HIV exposure/ transmission?
i
Does national law refrain from criminalizing HIV exposure/transmission?
ii
Has law-enforcement policy avoided arrests/prosecution for HIV transmission/exposure in recent years?
S5
Non-discrimination protections (3‑part)
S5
Non-discrimination protections
Structural
Policy 5
Do national laws/policies include protections from discrimination on the basis of sexual orientation, gender identity, and HIV status?
Data available for
i
2017
2018
2019
2020
2021
2022
2023
2024
Source: ILGA (2023)
ii
2017
2018
2019
2020
2021
2022
2023
2024
Sources: NCPI Part A (2019)ILGA (2023)
iii
2017
2018
2019
2020
2021
2022
2023
2024
Source: NCPI Part A (2022)
Do national laws/policies include protections from discrimination on the basis of sexual orientation, gender identity, and HIV status?
i
Do national laws protect people from discrimination on the basis of sexual orientation?
ii
Do national laws protect people from discrimination on the basis of gender identity/diversity?
iii
Do national laws protect people from discrimination on the basis of HIV status?
S6
National human rights institutions
S6
National human rights institutions
Structural
Policy 6
Is there an independent national human rights institution to which violations can be reported?
Data available for
2017
2018
2019
2020
2021
2022
2023
2024
Source: (2022)_GANHRI_Status of Accreditation
Is there an independent national human rights institution to which violations can be reported?
S7
Constitutional right to health
S7
Constitutional right to health
Structural
Policy 7
Is there an enforceable right to health in the national constitution?
Data available for
2017
2018
2019
2020
2021
2022
2023
2024
Source: Constitute (2021)
Is there an enforceable right to health in the national constitution?
S8
Girls education
S8
Girls education
Structural
Policy 8
Is there a national policy in place to encourage secondary school retention among girls?
Data available for
2017
2018
2019
2020
2021
2022
2023
2024
Source: UNICEF Strategic Plan 2014-17 Output Indicators (2018)
Is there a national policy in place to encourage secondary school retention among girls?
S9
Gender based violence
S9
Gender based violence
Structural
Policy 9
Does the law explicitly address domestic violence with enforceable penalties?
Data available for
2017
2018
2019
2020
2021
2022
2023
2024
Source: World Bank Women Business and the Law (2023)
Does the law explicitly address domestic violence with enforceable penalties?
S10
Civil society (2‑part)
S10
Civil society
Structural
Policy 10
Are NGOs/CSOs able to register, seek funding and operate freely under national law and is there a social contracting policy for financing NGOs/CSO-provided services?
Data available for
i
2017
2018
2019
2020
2021
2022
2023
2024
Source: NCPI Part B (2022)
ii
2017
2018
2019
2020
2021
2022
2023
2024
Source: (2022)_Freedom_in_the_world_All_data_2013-2022
Are NGOs/CSOs able to register, seek funding and operate freely under national law and is there a social contracting policy for financing NGOs/CSO-provided services?
i
Does national policy provide for social contracting (or other mechanisms by which the government finances CSOs to provide health services)?
ii
Are NGOs/CSOs, including those working with key populations, able to officially register, seek funding, and operate freely under national laws and policies?
Health systems
Contact Us
HS
MANY
Category / topic
Question
Adoption level
Not
adopted
Partially
adopted
Adopted
HS1
Task shifting
HS1
Task shifting
Health systems
Policy 1
Are nurses or other non-physicians allowed to initiate HIV treatment under national policy?
Data available for
2017
2018
2019
2020
2021
2022
2023
2024
Source: NCPI (2020)
Are nurses or other non-physicians allowed to initiate HIV treatment under national policy?
HS2
Health financing (2‑part)
HS2
Health financing
Health systems
Policy 2
Does the national budget and fiscal policy include sufficient health spending and adequate tax revenues to meet international targets?
Data available for
i
2017
2018
2019
2020
2021
2022
2023
2024
Source data not currently available
ii
2017
2018
2019
2020
2021
2022
2023
2024
Source data not currently available
Does the national budget and fiscal policy include sufficient health spending and adequate tax revenues to meet international targets?
i
Does the percent of government spending going to health align with the Global Fund co-financing targets?
ii
Does government collect adequate tax revenue to align with the tax:GDP ratio in the Global Fund co-financing targets?
data not available
HS3
Universal health coverage (2‑part)
HS3
Universal health coverage
Health systems
Policy 3
Does national health coverage include medications for HIV treatment & pre-exposure prophylaxis (PrEP)?
Data available for
i
2017
2018
2019
2020
2021
2022
2023
2024
Source: NCPI (2020)
ii
2017
2018
2019
2020
2021
2022
2023
2024
Source: NCPI (2020)
Does national health coverage include medications for HIV treatment & pre-exposure prophylaxis (PrEP)?
i
Are ARVs covered by the national health system/scheme?
ii
Is PrEP covered by the national health system/scheme?
HS4
User fees (2‑part)
HS4
User fees
Health systems
Policy 4
Are public primary healthcare and HIV services available without user fees at the point of service under national policy?
Data available for
i
2017
2018
2019
2020
2021
2022
2023
2024
Source data not currently available
ii
2017
2018
2019
2020
2021
2022
2023
2024
Source data not currently available
Are public primary healthcare and HIV services available without user fees at the point of service under national policy?
data not available
i
Are primary healthcare services in public facilities available without user fees?
data not available
ii
Are HIV services in public facilities available without user fees?
data not available
HS5
Access to medicines (TRIPS) (2‑part)
HS5
Access to medicines (TRIPS)
Health systems
Policy 5
Does national law/policy take advantage of TRIPS flexibilities for affordable medicines?
Data available for
i
2017
2018
2019
2020
2021
2022
2023
2024
Sources: article 9(4) Protection against unfair competition act of 2006"Article 32(4)(a), 34(4)-(5) of the Patents Act, 2018 No. 22 of 2018Section 11 (4)(a), Sections 13-14 of the Patent Act No. 23 of 2003
ii
2017
2018
2019
2020
2021
2022
2023
2024
Source: Medicines, Law & Policy (2021)
Does national law/policy take advantage of TRIPS flexibilities for affordable medicines?
i
Are TRIPS flexibilities (including parallel importation, compulsory licensing, and LDC extension) incorporated in national law?
ii
Are there documented examples of the country utilizing TRIPS flexibilities?
HS6
Unique identifiers with data protections (2‑part)
HS6
Unique identifiers with data protections
Health systems
Policy 6
Are unique identifiers for continuity of care across multiple facilities included in national policy along with protections for patients' privacy?
Data available for
i
2017
2018
2019
2020
2021
2022
2023
2024
Source: NCPI (2018)
ii
2017
2018
2019
2020
2021
2022
2023
2024
Source data not currently available
Are unique identifiers for continuity of care across multiple facilities included in national policy along with protections for patients' privacy?
i
Is there a unique ID (or other method of de-duplicating data) that allows for continuity of care across multiple facilities?
ii
Does national law include legally enforceable protections against disclosure of individually-identifiable health data, including HIV status?
data not available
HS7
Data sharing (2‑part)
HS7
Data sharing
Health systems
Policy 7
Is it national policy to publicly share disaggregated HIV data on a regular basis?
Data available for
i
2017
2018
2019
2020
2021
2022
2023
2024
Source data not currently available
ii
2017
2018
2019
2020
2021
2022
2023
2024
Source data not currently available
Is it national policy to publicly share disaggregated HIV data on a regular basis?
data not available
i
Is data disaggregated by geographic region, age, and gender?
data not available
ii
Is data shared at least quarterly?
data not available